FAVISH MICHAEL 4
4 · Guardion Health Sciences, Inc. · Filed Apr 10, 2019
Insider Transaction Report
Form 4
FAVISH MICHAEL
DirectorChair, Chief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2019-04-09+1,250,000→ 1,250,000 totalExercise: $4.40Exp: 2024-04-09→ Common Stock (1,250,000 underlying) - Award
Common Stock
2019-04-09$4.00/sh+1,000$4,000→ 1,000 total
Holdings
- 3,117,647(indirect: By Trust)
Common Stock
- 130,000(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The Option shall vest ratably over three years commencing one twelfth on June 30, 2019, and one twelfth at the end of each calendar quarter thereafter until fully vested.